| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
102,087,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
3,941,702 |
Avg
Vol: |
1,828,512 |
| 52
Week Range: |
$45.85 - $45.85 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Coles N Anthony |
President, COO & Director |
• • – |
2008-03-17 |
4 |
D |
$3.85 |
$240,902 |
D/D |
(62,572) |
220,066 |
|
- |
|
| Coles N Anthony |
President, COO & Director |
• • – |
2008-03-17 |
4 |
A |
$0.00 |
$0 |
D/D |
135,000 |
282,638 |
|
- |
|
| Bvf Inc/il |
Indirect Beneficial Owner |
– – • |
2008-03-14 |
4 |
B |
$3.84 |
$384,450 |
I/I |
100,000 |
4,809,015 |
1.5 |
- |
|
| Coles N Anthony |
President, COO & Director |
• • – |
2008-03-14 |
4 |
A |
$0.00 |
$0 |
D/D |
76,336 |
147,638 |
|
- |
|
| Bvf Inc/il |
Indirect Beneficial Owner |
– – • |
2008-03-13 |
4 |
B |
$3.77 |
$31,284 |
I/I |
8,300 |
4,709,015 |
1.5 |
- |
|
| Bvf Inc/il |
Indirect Beneficial Owner |
– – • |
2008-03-12 |
4 |
B |
$3.82 |
$147,452 |
I/I |
38,600 |
4,700,715 |
1.5 |
- |
|
| Bvf Inc/il |
Indirect Beneficial Owner |
– – • |
2008-03-11 |
4 |
B |
$3.71 |
$200,217 |
I/I |
53,900 |
4,662,115 |
1.5 |
- |
|
| Bvf Inc/il |
Indirect Beneficial Owner |
– – • |
2008-03-10 |
4 |
B |
$3.73 |
$469,350 |
I/I |
126,000 |
4,608,215 |
1.5 |
- |
|
| Bvf Inc/il |
Indirect Beneficial Owner |
– – • |
2008-03-07 |
4 |
B |
$3.81 |
$556,057 |
I/I |
146,100 |
4,482,215 |
1.5 |
- |
|
| Biotechnology Value Fund Ii Lp |
10% Owner |
– – • |
2008-03-06 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,336,115 |
|
- |
|
| Coles N Anthony |
President, COO & Director |
• • – |
2008-01-11 |
4 |
D |
$3.87 |
$35,999 |
D/D |
(9,302) |
69,317 |
|
- |
|
| Coles N Anthony |
President, COO & Director |
• • – |
2008-01-11 |
4 |
A |
$0.00 |
$0 |
D/D |
25,839 |
78,619 |
|
- |
|
| Tombros Peter G |
Director |
– • – |
2007-11-16 |
4 |
B |
$4.27 |
$43,391 |
D/D |
10,000 |
26,500 |
2.39 |
- |
|
| Coles N Anthony |
President, COO & Director |
• • – |
2007-11-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
45,000 |
52,780 |
|
- |
|
| Klein Joseph III |
as of May 22, 2007 |
– – – |
2007-05-23 |
4 |
S |
$4.05 |
$154,670 |
D/D |
(38,100) |
0 |
|
- |
|
| Coles N Anthony |
CEO, President and Director |
• • – |
2007-01-31 |
4 |
A |
$3.22 |
$25,052 |
D/D |
7,780 |
7,780 |
|
- |
|
| Antczak Val R |
Snr. V.P., General Counsel |
• – – |
2006-07-31 |
4 |
A |
$3.32 |
$5,695 |
D/D |
1,718 |
26,776 |
|
- |
|
| Antczak Val R |
Senior VP, Legal Affairs |
• – – |
2006-06-15 |
4 |
B |
$5.16 |
$20,640 |
D/D |
4,000 |
25,058 |
2.74 |
- |
|
| Jackson Hunter |
Director |
– • – |
2006-06-15 |
4 |
B |
$4.80 |
$998 |
I/I |
208 |
240 |
2.02 |
- |
|
| Lasowski Juergen |
Senior VP Business Development |
• – – |
2006-06-14 |
4 |
B |
$4.74 |
$50,244 |
D/D |
10,600 |
20,220 |
2.74 |
- |
|
| Parrish Stephen R |
VP, Manufacturing |
• – – |
2006-06-14 |
4 |
B |
$4.76 |
$23,775 |
D/D |
5,000 |
9,829 |
2.74 |
- |
|
| Nader Francois |
Chief Medical & Commercial Off |
• – – |
2006-06-05 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
19,350 |
|
- |
|
| Lasowski Juergen |
Senior VP Business Development |
• – – |
2006-05-10 |
4 |
B |
$5.20 |
$50,024 |
D/D |
9,620 |
9,620 |
2.74 |
- |
|
| Rauch Alan Mark |
VP, Chief Medical Officer |
• – – |
2006-01-31 |
4 |
A |
$9.38 |
$21,245 |
D/D |
2,266 |
2,521 |
|
- |
|
| Parrish Stephen R |
VP, Manufacturing |
• – – |
2006-01-31 |
4 |
A |
$9.38 |
$21,254 |
D/D |
2,267 |
4,829 |
|
- |
|
574 Records found
|
|
Page 10 of 23 |
|
|
